Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 27, 2023

BUY
$13.31 - $19.86 $55,369 - $82,617
4,160 Added 868.48%
4,639 $92,000
Q4 2022

Feb 02, 2023

SELL
$12.74 - $15.12 $50,144 - $59,512
-3,936 Reduced 89.15%
479 $6,000
Q3 2022

Nov 04, 2022

BUY
$12.93 - $17.17 $57,085 - $75,805
4,415 New
4,415 $61,000
Q2 2022

Aug 03, 2022

SELL
$13.53 - $23.34 $134,907 - $232,723
-9,971 Closed
0 $0
Q1 2022

May 02, 2022

BUY
$16.14 - $22.6 $113,012 - $158,245
7,002 Added 235.84%
9,971 $225,000
Q4 2021

Feb 23, 2022

SELL
$18.64 - $36.77 $13,905 - $27,430
-746 Reduced 20.08%
2,969 $55,000
Q3 2021

Oct 28, 2021

SELL
$32.83 - $43.0 $39,396 - $51,600
-1,200 Reduced 24.42%
3,715 $158,000
Q2 2021

Aug 12, 2021

BUY
$34.41 - $44.03 $146,793 - $187,831
4,266 Added 657.32%
4,915 $209,000
Q1 2021

Apr 26, 2021

SELL
$37.29 - $47.19 $512,849 - $649,004
-13,753 Reduced 95.49%
649 $24,000
Q4 2020

Feb 02, 2021

BUY
$34.3 - $44.09 $387,075 - $497,555
11,285 Added 362.05%
14,402 $630,000
Q3 2020

Oct 14, 2020

BUY
$27.86 - $39.35 $86,839 - $122,653
3,117 New
3,117 $122,000
Q2 2020

Jul 13, 2020

SELL
$30.3 - $42.55 $133,168 - $187,007
-4,395 Closed
0 $0
Q1 2020

Apr 29, 2020

BUY
$30.0 - $54.18 $118,620 - $214,227
3,954 Added 896.6%
4,395 $154,000
Q4 2019

Feb 05, 2020

SELL
$42.29 - $52.2 $361,410 - $446,101
-8,546 Reduced 95.09%
441 $21,000
Q3 2019

Oct 15, 2019

BUY
$42.06 - $51.64 $377,993 - $464,088
8,987 New
8,987 $427,000
Q1 2018

Apr 26, 2018

SELL
$21.05 - $26.6 $10,819 - $13,672
-514 Closed
0 $0
Q4 2017

Jan 10, 2018

BUY
$23.37 - $29.26 $5,258 - $6,583
225 Added 77.85%
514 $12,000
Q3 2017

Oct 25, 2017

BUY
$27.25 - $31.55 $7,875 - $9,117
289
289 $8,000

Others Institutions Holding CSII

About Cardiovascular Systems Inc


  • Ticker CSII
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 41,905,900
  • Description
  • Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...
More about CSII
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.